Spot the signals.
Clinical trial surveillance, patent intelligence, and biomarker strategy — built from public FDA and ClinicalTrials.gov data.
Clinical Program Risk Radar
Track public delay, termination, recruitment burden, and missing-results signals across oncology Phase 2 assets.
Generic Entry Radar
Screen U.S. small-molecule drugs for near-term loss-of-exclusivity windows, scored by expiry attractiveness and patent complexity.
ADC Target Strategy Radar
Map oncology ADC targets by clinical crowding, sponsor competition, patent-density signals, and strategic labels.
Translational Deal Radar
Screen translational programs for clinical momentum, IP-linkage signals, and BD relevance before deeper diligence begins.
Protocol Benchmark Radar
Benchmark public trial designs by endpoint precedent, eligibility burden, biomarker strategy, and operational risk.
Biomarker Patient-Selection Radar
Track how oncology biomarkers are used for patient selection, with FDA CDx context and diagnostic patent-density signals.
Structured outputs
Public biomedical databases are searchable, but search is not intelligence. Treelip transforms raw records into decision-specific modules with structured outputs, confidence labels, and evidence trails.
Explainable signals
Every signal is source-linked, clearly labelled, and explainable. Conservative interpretation, transparent methodology, and manual-review flags — not black-box claims.
Compounding intelligence
Treelip becomes more valuable as it accumulates historical snapshots, change events, entity mappings, and watchlists. The long-term moat is the curated, versioned intelligence layer.
A practical intelligence layer for pharma strategy
Treelip is an independent platform that builds deterministic, public-data intelligence tools for pharma BD, strategy, and market intelligence teams. Each module is built from public databases — FDA Orange Book, ClinicalTrials.gov, and related public sources — with transparent methodology pages explaining every signal.
Outputs are designed for first-pass prioritisation and expert review support, not automated decisions. Treelip does not replace expert clinical, legal, regulatory, or investment judgment. It helps experts focus their attention faster.
How Treelip is delivered: Public teaser dashboards · Gated CSV downloads · Monthly intelligence briefs · Custom asset or target reports · Watchlist monitoring.
Stay ahead of what's moving in pharma
Enter your name and email to register interest. We use this to manage email subscriptions, future CSV delivery, and product access follow-up.